Literature DB >> 10150709

Patients' interpretations of verbal expressions of probability: implications for securing informed consent to medical interventions.

D J Mazur1, J F Merz.   

Abstract

Physicians often use verbal expressions of probability to characterize their uncertainty about outcomes and the risks or side effects of proposed therapies. However, there is an extensive literature that documents the inherent vagueness of such expressions. Because of the potential importance of probability terms to physician-patient communication and decision-making, we asked patients to tell us the odds they thought applicable to the term "rare," as used by their physician to discuss the likelihood of an adverse outcome from surgery. Patients were randomly assigned to one of three outcome groups: death, severe heart attack, or severe pneumonia. Demographic data were elicited from each subject, as were indicators of present health status, medical history for certain diseases and surgery, and life expectancy. Linear regression and ANOVA analyses of the responses indicate that patient age, education level, perceived health status, and recency of experience with disease and medical care influence patients' numeric interpretations. We discuss the implications of these results.

Entities:  

Mesh:

Year:  1994        PMID: 10150709     DOI: 10.1002/bsl.2370120410

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  11 in total

Review 1.  Understanding risk and lessons for clinical risk communication about treatment preferences.

Authors:  A Edwards; G Elwyn
Journal:  Qual Health Care       Date:  2001-09

Review 2.  Increasing informed uptake and non-uptake of screening: evidence from a systematic review.

Authors:  R G Jepson; C A Forbes; A J Sowden; R A Lewis
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

3.  Patients' perceptions of omitted examinations and tests: A qualitative analysis.

Authors:  R L Kravitz; E J Callahan
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

4.  Risky communication: pitfalls in counseling about risk, and how to avoid them.

Authors:  K O'Doherty; G K Suthers
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.537

5.  Effect of Communication Style on Perceptions of Medication Side Effect Risk among Pharmacy Students.

Authors:  Ruta V Sawant; Collin R Beatty; Sujit S Sansgiry
Journal:  Am J Pharm Educ       Date:  2016-10-25       Impact factor: 2.047

Review 6.  Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Authors:  Dianne C Berry; D K Raynor; Peter Knapp; Elisabetta Bersellini
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Authors:  Kala Visvanathan; Rowan T Chlebowski; Patricia Hurley; Nananda F Col; Mary Ropka; Deborah Collyar; Monica Morrow; Carolyn Runowicz; Kathleen I Pritchard; Karen Hagerty; Banu Arun; Judy Garber; Victor G Vogel; James L Wade; Powel Brown; Jack Cuzick; Barnett S Kramer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

8.  Hedging their mets: the use of uncertainty terms in clinical documents and its potential implications when sharing the documents with patients.

Authors:  David A Hanauer; Yang Liu; Qiaozhu Mei; Frank J Manion; Ulysses J Balis; Kai Zheng
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

9.  The interpretation of phrases used to describe uncertainty in pathology reports.

Authors:  Malcolm Galloway; Taj Taiyeb
Journal:  Patholog Res Int       Date:  2011-08-14

10.  How should risk be communicated to children: a cross-sectional study comparing different formats of probability information.

Authors:  Fiona Ulph; Ellen Townsend; Cris Glazebrook
Journal:  BMC Med Inform Decis Mak       Date:  2009-06-05       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.